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Abstract Mammals coexist with an extremely dense
microbiota in the lower intestine. Despite the constant
challenge of small numbers of microbes penetrating the
intestinal surface epithelium, it is very unusual for these
organisms to cause disease. In this review article, we
present the different mucosal firewalls that contain and
allow mutualism with the intestinal microbiota.
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Introduction
The lower intestine is colonized with a very dense micro-
biota of up to 1012 colony-forming units per gram of
intestinal contents. This density is considerably higher than
found in most other microbiological populations, including
soils and subsurfaces [1]. It also means that the total load
(about 1014) of microorganisms in the human intestine is an
order of magnitude greater than the cells in the body (about
1013).
Many of the beneficial effects of the intestinal micro-
biota have been well known for decades. They are
important to salvage energy from otherwise indigestible
foods, they take up space in the microbial niche and limit
access for pathogens, and they provide the host with
vitamins. These interactions were first discovered in the
first half of the twentieth century after it became possible to
breed experimental animals in germ-free conditions and so
animals with and without an intestinal microbiota could be
compared [2]. Subsequent experiments have shown that the
intestinal microbiota also shapes the host, for example,
Peyer's patches and intestinal lymphoid follicles are
hypoplastic under germ-free conditions [3]. The intestinal
contents of IgA-producing plasma cells [4], CD4 lamina
propria T cells, and intraepithelial αβCD8 T cells carrying
the αβ T cell receptor [5] are only present in normal
quantities in mice with a normal commensal intestinal
microbiota. Germ-free experimentation with strains of mice
carrying targeted genetic deficiencies or using modern
techniques to measure gene expression have shown that
the relationship between host and microbiota is even
extensive than originally thought, affecting not only
immune cell populations and intestinal epithelial gene
expression [6, 7], but also the function of most body
systems and regulation of central body metabolism [2, 8].
Although most individuals coexist harmoniously with
commensal microbiota, hardly noticing the presence of
these little passengers except during visits to the toilet,
much intestinal disease directly or indirectly involves
imbalance in the relationship. Crohn's disease can arise
from mutations in the NOD2/CARD15 gene [9–11] that
senses the bacterial cell wall breakdown molecule muramyl
dipeptide [12], and both clinical and animal model evidence
implicate an imbalance in the host–microbial relationship as
a key factor that underlies the condition [13]. Functional
intestinal disease can arise from failed absorption of dietary
carbohydrates in the jejunum with subsequent bacterial
fermentation when the carbon sources reach the terminal
ileum or colon. Abnormal colonization of the upper small
intestine or blind intestinal loops with commensal organ-
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isms results in digestive disturbance and functional symp-
toms: this can also be a secondary consequence of drug
treatments or motility disturbances in systemic disease.
Intestinal bacteria also play an adjuvant role in intestinal
tumors and enteropathies induced by antibiotics or other
drugs [14].
Although the direct consequences of immunodeficien-
cies or dysfunction in the mucosal immune system are
important in generating intestinal pathology from disrupted
host–microbial mutualism, it is also important to consider
how disruption of the barriers between host and microbe
affect systemic pathology. It is clear that individuals that are
compromised through immunosuppression through drugs,
radiotherapy, or immune deficiency have increased suscep-
tibility to sepsis from their commensal microbiota [15].
This review considers the barriers to commensal penetra-
tion from the intestinal lumen to the underlying tissues of
the body and the possible relevance of these to human
disease.
Firewalls against commensal intestinal bacteria
The epithelial cell layer
The primary barrier against the penetration of microorgan-
isms and large molecules from the lumen of the intestine is
the simple epithelium of a single layer of enterocytes,
overlaid with mucus and joined together by junctional
complexes. Healthy barrier function also depends on
crosstalk with intraepithelial lymphocytes, which are
required for the production of trophic factors and repair of
damaged or dead cells [16, 17]. The importance of this
barrier can be shown from spontaneous intestinal inflam-
mation which occurs in mice colonized with intestinal
bacteria that carry genetic deficiencies in mucin production
or formation of the intraepithelial cell complexes [18, 19].
In clinical practice, it is possible to measure the trans-
epithelial cellular permeability to macromolecules using
noninvasive tests of selective sugar permeability, which
depend on differential excretion of the test sugars (e.g.,
lactulose/rhamnose) in the urine. These measurements show
that everyday challenges to the intestine result in increased
permeability across the intestinal epithelial layer. Examples
include subclinical infections, intake of alcohol, spicy
foods, drugs such as the nonsteroidal anti-inflammatory
agents, and even stress [20]. It is hardly surprising that
more severe challenges to epithelial cells, including
radiation damage, acute toxicity from chemotherapeutic
agents, and graft-versus-host disease, have even more
dramatic effects on permeability [20]. In humans, it is hard
to distinguish the contribution of penetration of intestinal
bacteria or their molecules from penetration of other
molecular components of the luminal contents, although
pretreatment with antibiotics to reduce the luminal load of
intestinal bacteria is routinely used as part of the protocol in
bone marrow transplantation and to treat patients with
enteropathy generated with nonsteroidal anti-inflammatory
drugs. In mice, most models of chronic intestinal inflam-
mation that have been studied are either abolished or
dramatically attenuated, yet there is evidence that the
integrity of the epithelial barrier actually requires Toll-like
receptor signaling (TLR) [21, 22].
Apart from the physical barrier of the epithelial cell layer
and the overlying mucus, epithelial cells secrete small
antibacterial peptides (defensins and cathelicidins) and one
of the defects generated by deficient NOD2/CARD15
signaling in some cases of Crohn's disease is failure of
differentiation of the epithelial Paneth cell lineage, which
secrete these peptides [23–25]. A further genetic defect
identified in humans is a variation in the ATG16L1 gene
that mediates autophagy [26]. This mutant protein does not
appear to abrogate nonselective autophagy (the process of
formation of double-membrane cytosolic vesicles that
sequester parts of the cytoplasm and deliver them to the
lysosome for degradation). Instead, there appears to be a
defect in the exocytic pathway of Paneth cells, resulting in
impaired secretion of antibacterial peptides and lysozyme
[27].
The epithelial cell layer is also subject to a continuous
flow of IgA secretion through attachment of IgA to the
polymeric immunoglobulin receptor (pIgR) at the epithelial
basolateral surface and delivery through transepithelial
vesicular shuttling to the apical (luminal) surface [28, 29].
This continuous secretion of immunoglobulin has a high
capacity—typically 3 g IgA/day in humans—and presum-
ably contributes to clearance of the small number of
bacteria that penetrate the epithelial cell layer. The evidence
for this is largely indirect: polarized cell monolayers can
achieve IgA-dependent clearance of viruses [30, 31], and
there is immunoglobulin-dependent clearance of rotavirus
in vivo [32]. When the system does not work, in pathogen-
free pIgR-deficient mice colonized with a commensal
microbiota, intestinal dysfunction can be shown by a
protein-losing enteropathy [33]. Furthermore, one of the
cardinal clinical features of humans with common variable
immunodeficiency, lacking all isotypes of immunoglobulin,
is chronic intestinal inflammation which may present in
adult life and be confused with inflammatory bowel disease
or celiac sprue [34].
Subepithelial macrophages
As described in the previous section, the epithelial
permeability barrier is far from perfect in normal human
life, yet we still tolerate our intestinal microbiota despite
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drinking alcohol and taking nonsteroidal anti-inflammatory
drugs to mitigate the consequences. There are abundant
resident macrophages underneath the surface epithelium,
which also to contribute to the elimination of the small
number of microorganisms that reach the basolateral
surface of the intestinal epithelium through phagosome
biocidal killing mechanisms involving free radical perox-
idation [35]. Intestinal resident macrophages are normally
relatively noninflammatory with low expression of bacterial
receptor molecules, including TLR2, TLR4, and the CD14
lipopolysaccharide receptor, although increased IL-1 in-
flammatory responses are seen in the setting of mutations of
the ATG16L1 autophagy. Lamina propria CD4 T cells have
a limited effect on avoiding penetration of bacteria through
the intestinal firewall mainly by cytokine-dependent acti-
vation of intestinal macrophages [36–38].
There are three indirect lines of evidence that support the
role of intestinal macrophages in eliminating penetrant
commensal microorganisms. First, intestinal inflammation
occurs in colonized—but not germ-free—mice that are
deficient in the Stat3 signaling pathway from cytokines of
the IL-6 family in macrophages and neutrophils and,
therefore, cannot be properly activated [39]. Secondly,
mice deficient for biocidal killing mechanisms as a result of
targeted deficiency in the production of superoxide and
nitric oxide radicals are highly susceptible to spontaneous
death through commensal sepsis soon after weaning [40].
Chronic granulomatous disease in humans, which is also
caused by the inability to generate reactive superoxide
radicals, results in a severe intestinal enteropathy as well as
systemic opportunistic infections [41, 42]. Thirdly, many
intestinal bacterial pathogens, including Salmonella, Shi-
gella, and Yersinia, have strategies to evade macrophage
biocidal activation and establish a facultative intracellular
existence encoded by their genomic pathogenicity islands
as a critical part of their pathogenic potential [43].
Presumably, deficiency in the innate immune pathways of
these cells, such as in NOD2 Crohn's disease, is relevant for
human intestinal inflammation. It has been increasingly
recognized that many immunodeficiencies may present in
adult life with a narrow phenotype (without multiple
opportunistic infections), and different potential subtle
alterations of signaling in this cell type may be a promising
avenue to explain the large variety of different phenotypes
in human inflammatory bowel disease [44, 45].
Dendritic cell commensal sampling and the mesenteric
lymph node barrier
A barrier that totally excluded commensal intestinal micro-
organisms or their breakdown molecules would not allow
induction of responses by the intestinal mucosal immune
system against these organisms. It follows that some
leakiness of the epithelial cell barrier is required to allow
the immune system to sense microorganisms in the
intestine. This is achieved in several ways. First, a small
number of commensal bacteria can penetrate through the
specialized epithelium, rich in M cells, that overlies the
intestinal Peyer's patches and lymphoid follicles. These
bacteria are sampled by intestinal dendritic cells (DC)
which are capable of inducing both B and T cell mucosal
responses [46]. Alternatively, processes of DC can pene-
trate through the epithelial junctional complexes to sample
bacteria in the mucus layer or the lumen [47].
DC that have sampled intestinal bacteria (and induced
intestinal mucosal immune responses) are rather poor at
killing the sentinel bacteria, especially in comparison with
intestinal macrophages that lie in clusters underneath the
surface epithelium. However, DC laden with commensal
intestinal bacteria can home to the mesenteric lymph nodes,
but do not penetrate further to reach systemic tissues
elsewhere in the body [46]. It is assumed that the short
lifespan of the DC mean that they die in the mesenteric
lymph nodes and the bacteria they carry are released and
killed by resident macrophages. The net result of this is that
a mucosal immune response can be induced locally in the
intestinal mucosa, but penetration of the inducing DC
carrying intestinal bacteria into central systemic body
tissues is not required. In other words, the mesenteric
lymph nodes act as a firewall to limit mucosal immune
induction system to the mucosal immune system itself and
limit exposure to commensals elsewhere in the body.
It is clear that the firewall against commensal intestinal
bacteria functions in multiple layers. What relevance may
this have for human intestinal inflammatory pathogenesis?
There is recognition that alterations in immune function or
immunodeficiency may be more subtle than classically
described with the phenotype or disease only becoming
apparent in adult life and with a restricted range of
microorganisms that are responsible for the immunopathol-
ogy [45, 48]. This new paradigm may be very relevant for
many of the potential underlying defects for inflammatory
bowel disease where the firewalls against the abundant
microflora are tested continuously throughout life. Many
subclinical intestinal inflammatory conditions also exist
with unclear etiology that do not fit into the recognized
criteria for diagnosis of Crohn's disease or ulcerative colitis:
these may also be explainable in part by deficiencies of one
of the firewall layers that limit the penetration of our
abundant commensal intestinal microbiota.
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